Skip to content
  • Home
  • IOncology
  • Infectious Desease Frontier
  • IHepatology
  • Hematology Frontier
  • Conference topics
  • Experts Interviews
  • Informations
  • Live Broadcasting
  • Logout
MediaMedic

Connecting Medical Expertise through Media

  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
Headlines
Professor Ping Zhang at COMB 2025: Breaking Through Endocrine Resistance—New Precision Pathways for HR+/HER2- Breast Cancer
2025.09.14
Academician Xishan Hao: The Mission of Advancing Chinese Oncology and Building Academic Journal
2025.09.14
Professor Xiaowei Qi: Preferred Neoadjuvant Strategies in HER2-Positive Breast Cancer and Breakthrough Directions in TNBC Immunotherapy
2025.09.14
Professors Xuening Ji & Yuhua Song: Rescue Therapy in TNBC—Which Immunotherapy Combination Should Be Preferred?
2025.09.14
Professors Li Wang & Jianbin Li: Choosing Adjuvant Therapy for Intermediate-Risk HR+ Early Breast Cancer
2025.09.14
Professors Bin Song & Yuan Peng: How Should We Choose CDK4/6 Inhibitors for Adjuvant Endocrine Therapy Intensification?
2025.09.14
The 28th CSCO Annual Meeting Opens in Jinan
2025.09.14
Professors Ning Xie & Lingzhi Xu: ADC vs. Targeted Therapy + Endocrine Therapy in the Post-CDK4/6i Era
2025.09.13
Professor Cuizhi Geng: Advancing Standardized Care and Technological Innovation to Drive Homogeneity in Regional Breast Cancer Treatment
2025.09.12
Professor Yunjiang Liu: OPS and MDT as Twin Engines Driving Breast Cancer Treatment into the Era of “Precision Breast-Conservation”
2025.09.12
Posted inIOncology

Professor Ping Zhang at COMB 2025: Breaking Through Endocrine Resistance—New Precision Pathways for HR+/HER2- Breast Cancer

Posted by By Mourabit Halima 2025.09.14
Continue Reading
Posted inIOncology

Academician Xishan Hao: The Mission of Advancing Chinese Oncology and Building Academic Journal

Posted by By Peter W. PENG 2025.09.14
Continue Reading
CLL Breakthrough: BTK Degrader Bexobrutideg Shows Rapid, Durable Responses丨Professor Alexey Danilov on NX-5948

CLL Breakthrough: BTK Degrader Bexobrutideg Shows Rapid, Durable Responses丨Professor Alexey Danilov on NX-5948

Posted by By Mourabit Halima 2025.09.04
Editor's Note: At this conference, Professor Alexey Danilov (Professor of Hematology, Associate Director of the Lymphoma Center, and Director of the Early Therapeutics Program at City of Hope National Medical…
Read More
EO2463 Peptide Immunotherapy Shows Promise in Follicular and Marginal Zone Lymphoma丨18-ICML

EO2463 Peptide Immunotherapy Shows Promise in Follicular and Marginal Zone Lymphoma丨18-ICML

Posted by By Peter W. PENG 2025.09.04
Editor's Note: At ICML conference, Professor Jose C. Villa Boas from Rochester, USA, was invited to present an oral report titled "EO2463 Peptide Immunotherapy in Combination with Lenalidomide and Rituximab…
Read More
New Era in Non-Hodgkin Lymphoma: Professor Franck Morschhauser on Breakthrough Phase I Results of a Novel BCL6 Degrader

New Era in Non-Hodgkin Lymphoma: Professor Franck Morschhauser on Breakthrough Phase I Results of a Novel BCL6 Degrader

Posted by By Mourabit Halima 2025.09.04
Editor's Note: The conference brought together top experts in lymphoma research from home and abroad, engaging in in-depth discussions on cutting-edge topics such as novel molecular targeted therapies and cell…
Read More
Extranodal Lymphoma Treatment Enters a New Era: IELSG’s 30-Year Journey of Academic Breakthroughs and Future Prospects丨Memorial Lecture

Extranodal Lymphoma Treatment Enters a New Era: IELSG’s 30-Year Journey of Academic Breakthroughs and Future Prospects丨Memorial Lecture

Posted by By Mourabit Halima 2025.09.03
Editor's Note: The 18th International Conference on Malignant Lymphoma (ICML) was held, gathering top experts in the lymphoma field in Lugano. At the prestigious John Ultmann Memorial Lecture, Professor Emanuele…
Read More
A New Era in Molecular Subtyping of Aggressive B-cell Lymphoma: Professor David W. Scott on Genomics-Guided Precision Therapy丨EHA 2025

A New Era in Molecular Subtyping of Aggressive B-cell Lymphoma: Professor David W. Scott on Genomics-Guided Precision Therapy丨EHA 2025

Posted by By Ren Jiamo 2025.09.03
Editor's Note: In 2025, the International Conference on Malignant Lymphoma (ICML) convened in Switzerland, bringing together the world's leading experts in the field of lymphoma. At the conference, Professor David…
Read More
The Journey of Disease Discovery: Professor Elaine Jaffe Reviews a Century of Lymphoma Diagnosis and Classification

The Journey of Disease Discovery: Professor Elaine Jaffe Reviews a Century of Lymphoma Diagnosis and Classification

Posted by By Peng Longmei 2025.09.03
Editor's Note: The International Hematologic Oncology Pathology Conference brought together top experts in hematopathology research from home and abroad for in-depth discussions on cutting-edge topics such as lymphoma diagnosis, classification…
Read More

Professor Bruce D. Cheson on Breakthroughs in Lymphoma Treatment: Innovation Pathways and Future Vision丨EHA 2025

Posted by By Mourabit Halima 2025.09.03
Editor's Note: The conference focused on the latest diagnostic and therapeutic advances in lymphoid system tumors, providing a cutting-edge academic exchange platform for the global oncology community. At this prestigious…
Read More
Professor Yuzhu Shi: The Comprehensive Value of Abdominal CT in Managing Post-Transplant Complications丨13th Lu Daopei Hematology Conference

Professor Yuzhu Shi: The Comprehensive Value of Abdominal CT in Managing Post-Transplant Complications丨13th Lu Daopei Hematology Conference

Posted by By Peter W. PENG 2025.09.03
On August 22–23, 2025, the 13th Lu Daopei Hematology Conference was held in Beijing, jointly organized by the Beijing Health Promotion Association and the Guangzhou Kapok Oncology and Rare Disease…
Read More
Professor Hui Wang: Advancing MRD Detection in AML—From Standardization and Automation Toward Personalized Treatment

Professor Hui Wang: Advancing MRD Detection in AML—From Standardization and Automation Toward Personalized Treatment

Posted by By Mourabit Halima 2025.09.03
On August 22–23, 2025, the 13th Lu Daopei Hematology Conference was held in Beijing, jointly organized by the Beijing Health Promotion Association and the Guangzhou Kapok Oncology and Rare Disease…
Read More
Professor Tong Wang Analyzes the Clinical Challenges of Multilineage Involvement in BCR::ABL1-Positive B-ALL丨13th Lu Daopei Hematology Conference

Professor Tong Wang Analyzes the Clinical Challenges of Multilineage Involvement in BCR::ABL1-Positive B-ALL丨13th Lu Daopei Hematology Conference

Posted by By Peter W. PENG 2025.09.02
On August 22–23, 2025, the 13th Lu Daopei Hematology Conference was held in Beijing, jointly organized by the Beijing Health Promotion Association and the Guangzhou Kapok Oncology and Rare Disease…
Read More

Posts pagination

Previous page 1 2 3 4 5 … 20 Next page
Recent Posts
  • Professor Ping Zhang at COMB 2025: Breaking Through Endocrine Resistance—New Precision Pathways for HR+/HER2- Breast Cancer
  • Academician Xishan Hao: The Mission of Advancing Chinese Oncology and Building Academic Journal
  • Professor Xiaowei Qi: Preferred Neoadjuvant Strategies in HER2-Positive Breast Cancer and Breakthrough Directions in TNBC Immunotherapy
  • Professors Xuening Ji & Yuhua Song: Rescue Therapy in TNBC—Which Immunotherapy Combination Should Be Preferred?
  • Professors Li Wang & Jianbin Li: Choosing Adjuvant Therapy for Intermediate-Risk HR+ Early Breast Cancer
Recent Comments
    Archives
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • December 2023
    • November 2023
    • October 2023
    • August 2023
    Categories
    • Artificial intelligence
    • Hematology Frontier
    • Infectious Disease Frontier
    • International Hepatology
    • IOncology
    • Live broadcasting
    • Uncategorized
    • UroStream
    Post You Might Like
    Posted inIOncology
    Professor Ping Zhang at COMB 2025: Breaking Through Endocrine Resistance—New Precision Pathways for HR+/HER2- Breast Cancer
    Posted by By Mourabit Halima 2025.09.14
    Posted inIOncology
    Academician Xishan Hao: The Mission of Advancing Chinese Oncology and Building Academic Journal
    Posted by By Peter W. PENG 2025.09.14
    Posted inIOncology
    Professor Xiaowei Qi: Preferred Neoadjuvant Strategies in HER2-Positive Breast Cancer and Breakthrough Directions in TNBC Immunotherapy
    Posted by By Mourabit Halima 2025.09.14
    Posted inIOncology
    Professors Xuening Ji & Yuhua Song: Rescue Therapy in TNBC—Which Immunotherapy Combination Should Be Preferred?
    Posted by By Peng Longmei 2025.09.14
    • LinkedIn
    • Twitter
    • Mail
    Related Media:
    Copyright 2025 — MediaMedic. All rights reserved. Blogun WordPress Theme
    Media Medic Publishing Company Limited(HK)
    赛美出版有限公司(香港)
    Scroll to Top

    Welcome to Mediamedic 👋
    It’s nice to meet you.

    Dive into a world of trusted health insights. Subscribe for monthly updates straight to your inbox

    Privacy is part of our care. No spam, just wellness.

    🔒 Privacy policy

    Check your inbox or spam folder to confirm your subscription.

    • Facebook
    • X (Twitter)
    • LinkedIn
    • More Networks
    Share via
    Facebook
    X (Twitter)
    LinkedIn
    Mix
    Email
    Print
    Copy Link
    Copy link
    CopyCopied